SCHEMBL17953777

SCHEMBL17953777

c1ccc(-n2c3ccccc3c3c(-c4ccc(-c5ccc(-c6ccc7c8c(cccc68)-c6ccccc6-7)cc5)cc4)cccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
ATM Q13315 1/20 0.47
HDAC4 P56524 1/20 0.37
KEAP1 Q14145 2/20 0.37
NFE2L2 Q16236 2/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
MAPK14 Q16539 1/20 0.35
PABPC1 P11940 1/20 0.35
ALDH1A1 P00352 6/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
USP2 O75604 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
IL1R1 P14778 1/20 0.35
MEN1 O00255 2/20 0.34
POLB P06746 1/20 0.33
APOBEC3A P31941 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17953766 0.99 KDM4E (0.49) KDM4EL3MBTL1ATMHDAC4KEAP1
SCHEMBL17953773 0.90 L3MBTL1 (0.46) KDM4EL3MBTL1ATMKEAP1NFE2L2
SCHEMBL17953687 0.90 KDM4E (0.55) KDM4EL3MBTL1ATMKEAP1NFE2L2
SCHEMBL28317204 0.90 L3MBTL1 (0.55) KDM4EL3MBTL1ATMHDAC4MAPK14
SCHEMBL17953761 0.90 KDM4E (0.55) KDM4EL3MBTL1ATMKEAP1NFE2L2
SCHEMBL17953780 0.90 KDM4E (0.55) KDM4EL3MBTL1ATMKEAP1NFE2L2
SCHEMBL17953770 0.89 L3MBTL1 (0.42) KDM4EL3MBTL1ATMHDAC4KEAP1
SCHEMBL17953783 0.89 L3MBTL1 (0.45) KDM4EL3MBTL1ATMHDAC4KEAP1
SCHEMBL25674918 0.88 L3MBTL1 (0.58) KDM4EL3MBTL1ATMHDAC4MAPK14
SCHEMBL17953793 0.87 L3MBTL1 (0.44) KDM4EL3MBTL1ATMHDAC4KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10622569-B2 Compound, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-04-14 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EFNA1, L1CAM, LEF1 KDM4E 2030/4885L3MBTL1 1706/4885ATM 3520/4885
US-10622569-B2 Compound, organic electroluminescent element, and electronic device EFNA1, L1CAM, LEF1 KDM4E 2030/4885L3MBTL1 1706/4885ATM 3520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.